Effects of Qian Lie Shuang Granule on the Expression of IL-10, TNF- in the Rat Model for Chronic Abacterial Prostatitis

FAN Yu-dong; HU Meng-ying; ZHANG Lan-lan; HA Mu-la-ti; LIU Xiao-yan; XU Lei; PANG Shi-bing; JIN Hong-tao; SUN Yu-hua

您当前的位置：

首页 >

文章列表页 >

Effects of Qian Lie Shuang Granule on the Expression of IL-10, TNF- in the Rat Model for Chronic Abacterial Prostatitis

更新时间：2024-01-04

- Effects of Qian Lie Shuang Granule on the Expression of IL-10, TNF- in the Rat Model for Chronic Abacterial Prostatitis
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 18, Issue 19, Pages: 267-270(2012)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2012
- 稿件说明：
移动端阅览
FAN Yu-dong, HU Meng-ying, ZHANG Lan-lan, et al. Effects of Qian Lie Shuang Granule on the Expression of IL-10, TNF- in the Rat Model for Chronic Abacterial Prostatitis[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(19): 267-270.
DOI：

FAN Yu-dong, HU Meng-ying, ZHANG Lan-lan, et al. Effects of Qian Lie Shuang Granule on the Expression of IL-10, TNF- in the Rat Model for Chronic Abacterial Prostatitis[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(19): 267-270. DOI：

摘要

目的:观察前列爽颗粒对慢性前列腺炎(CAP)模型大鼠血清

白细胞介素-10(IL-10)和肿瘤坏死因子-α(TNF-α)表达的影响

并初步探讨其作用机制。方法:将60只SD大鼠随机分为正常对照组、CAP模型组、前列回春胶囊组(0.18g·kg-1)、前列爽低剂量组(0.79g·kg-1)、前列爽中剂量组(1.58g·kg-1)、前列爽高剂量组(3.15g·kg-1)

每组10只。观察大鼠前列腺病理形态学改变

ELISA法检测IL-10

TNF-α。结果:CAP模型大鼠的组织病理学改变符合CAP的特点

治疗组炎症明显消退。模型组血清中IL-10

TNF-α水平明显高于正常组(P<0.05)

前列回春胶囊组、前列爽颗粒中、高剂量组血清TNF-α水平明显低于模型组(P<0.05)

前列回春胶囊组、前列爽颗粒中、高剂量组

血清中IL-10水平明显升高。结论:前列爽颗粒可通过调节抗炎/促炎因子分泌而发挥治疗CAP的作用。

Abstract

Objective:Investigate the influence of Qianlie Shuang granule on intereukin-10(IL-10)

tumor necrosis factor-α(TNF-α) in serum of chronic abacterial prostafitis(CAP)rats. Method:Sixty aged sprague dawley (SD) rats were randomly divided into six groups:control group

model group

Qianlie Huichun granule group

Qianlie Shuang low dose group

Qianlie Shuang medium dose group and Qianlie Shuang high dose group. The changes of prostate gland inflammation was investigated. The expression of IL-10 and TNF-α in rat prostatic tissue was detected by immunohistochemistry. Result:The inflammation of model group were similar to those in clinical CAP

the inflammation of treatment groups were obviously degraded. The IL-10 and TNF-α in model group were obviously higher than in control group(P<0.05).The TNF-α in Qianlie Huichun granule group

Qianlie Shuang medium dose group and high dose group were obviously lower than in model group. The IL-10 in those groups were obviously higher than in model group. Conclusions:Qianlie Shuang granule can regulate the secretion of inflammatory cytokines

which can be one of the mechanisms in the therapy of CAP.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Inhibitory Effect and Antiangiogenesis of Gubenxiaoliu Capsule on Lewis Lung Carcinoma of Mouse

Effect of Qianlieshukang Capsule on Pathomorphology of Prostate and the Tissues of Prostatitis in Model Rats

Effect of Qianlie Shukang Capsule on Pathomorphology of Prostate and the Tissues of Prostatitis in Model Rats

The Expression of Bax Proteinum of Fructus Corni Polysaccharides in Human Cervical Cancer Cells

Related Author

WANG Xiao-min3

GAO Ya-bing3

PENG-Rui-yun3

WANG Zheng2

WANG Xiao-min1

YANG Guo-wang1

TENG Bao-xia

LIU Li -chun

Related Institution

Institute of Guangxi Medicinal Plant

Guangxi Institute of Chinese Medicine & Pharmaceutical Science

Lanzhou Taibao Pharmaceutical Co.Ltd.

The People’s Hospital of Gansu Province

Institute for drug Control of Gansu Province

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰